Taiwan Liposome Company, Ltd. Unsponsored ADR EBITDA Margin 2019-2021 | TLC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Taiwan Liposome Company, Ltd. Unsponsored ADR (TLC) over the last 10 years. The current EBITDA margin for Taiwan Liposome Company, Ltd. Unsponsored ADR as of June 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-06-30 | $0.01B | $-0.03B | -280.00% |
| 2021-03-31 | $0.00B | $-0.03B | -850.00% |
| 2020-12-31 | $0.00B | $-0.03B | -1133.33% |
| 2020-09-30 | $0.00B | $-0.03B | -1066.67% |
| 2020-06-30 | $0.00B | $-0.03B | -1450.00% |
| 2020-03-31 | $0.00B | $-0.03B | -933.33% |
| 2019-12-31 | $0.01B | $-0.02B | -300.00% |
| 2019-09-30 | $0.01B | $-0.02B | -300.00% |
| 2019-06-30 | $0.01B | $-0.03B | -312.50% |
| 2019-03-31 | $0.01B | $-0.03B | -312.50% |
| 2018-12-31 | $0.00B | $-0.03B | -900.00% |
